Concepedia
Statistics
Publications
17
Citations
798
H-Index
13
Active since
1989
Affiliations
New York University(Current)
Columbia University Irving Medical Center
Cornell University
Stanley Foundation
European Institute of Oncology
Joan Sorich is an author at New York University specializing in medicine, chemotherapy, and oncology.
Publications per year
1989–2005
Phase I trial of low-dose continuous topotecan infusion in patients with cancer: an active and well-tolerated regimen.
Howard S. Höchster, Leonard Liebes, James L. Speyer et al. · Journal of Clinical Oncology · 1994 · 165 citations
Medicine, Oncology, Pharmacotherapy +17
Activity and Pharmacodynamics of 21-Day Topotecan Infusion in Patients With Ovarian Cancer Previously Treated With Platinum-Based Chemotherapy
Howard S. Höchster, Scott Wadler, Carolyn D. Runowicz et al. · Journal of Clinical Oncology · 1999 · 88 citations
Medicine, Oncology, Pharmacology +17
Phase II trial of paclitaxel and cisplatin in women with advanced breast cancer: an active regimen with limiting neurotoxicity.
Carolyn Wasserheit, Andrea Frazein, Ruth Oratz et al. · Journal of Clinical Oncology · 1996 · 87 citations
Medicine, Oncology, Pharmacology +15
Expression of the Cell Cycle Inhibitor p27KIP1 Is a New Prognostic Marker Associated with Survival in Epithelial Ovarian Tumors
Elizabeth W. Newcomb, Meg Sosnow, Rita I. Demopoulos et al. · American Journal Of Pathology · 1999 · 81 citations · Full text
Medicine, Gynecology, Oncology +17
Intraperitoneal carboplatin: favorable results in women with minimal residual ovarian cancer after cisplatin therapy.
James L. Speyer, Uziel Beller, Nicoletta Colombo et al. · Journal of Clinical Oncology · 1990 · 73 citations
Medicine, Oncology, Pharmacology +12
1–5 of 17